about
Molecular and cell-based therapies for muscle degenerations: a road under constructionDermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residuesA randomized pilot study of atractylenolide I on gastric cancer cachexia patientsDecreased Jun-D and myogenin expression in muscle wasting of human cachexiaA neural survival factor is a candidate oncogene in breast cancerThe presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour.Dermcidin: a novel human antibiotic peptide secreted by sweat glandsStructural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradationTorbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic ratsActivation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alphaEffect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradationCancer cachexia: impact, mechanisms and emerging treatmentsMetformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing ratsReview: the use of proteomics as a research methodology for studying cancer-related fatigue: a review.Apoptosis of muscle cells causes weight loss prior to impairment of DNA synthesis in tumor-bearing rabbits.Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes.The anti-cachectic effect of fatty acids.Inflammation based regulation of cancer cachexiaTreatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's diseaseAnalysis of Y-P30/Dermcidin expression and properties of the Y-P30 peptideRole of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice.NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.Molecular pathways leading to cancer cachexia.Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.A sustained rat model for studying the long-lasting catabolic state of sepsis.Novel treatments for cancer cachexia.Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients.Induction of muscle protein degradation by a tumour factorMechanism of muscle protein degradation induced by a cancer cachectic factorManagement of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies.Nutrition modulation of cachexia/proteolysis.Cancer cachexia: mechanisms and clinical implications.Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicityPancreatic cancer cachexia: a review of mechanisms and therapeutics.HSP70 natively and specifically associates with an N-terminal dermcidin-derived peptide that contains an HLA-A*03 antigenic epitope.
P2860
Q24568176-6BD63387-9CAB-4E9A-A8B7-3D781E35B290Q24651498-4FBA986E-BD8F-463E-AA31-25A535BC4365Q24654205-97B260A5-8757-4331-8C57-8EFB78122525Q24654557-362F3C26-3604-441B-AC96-9C39E375AD86Q24685777-52DF32D1-1EAB-41FC-AD23-886DEB57FDBEQ24811905-C9DF41C3-00A8-4D80-B009-4C47DBBA8AB0Q28203903-8F66CCF5-F24A-475E-939A-5B5C8832E46EQ28237250-FA8C5C6F-7B78-4BD3-9F87-1F03C3CB576BQ28344272-C581E603-772D-45B6-A687-4C99A1CFA985Q28344353-57930199-37A4-45F7-A5C7-8966C31CFA93Q28365498-1FBDE6D7-492E-490C-87C1-FC4BE7E9C3F3Q28366619-6E3D7DDA-0598-4879-96C9-E9342C5BCA3AQ28384479-B8ECED18-D72D-481D-9116-152925CFB70EQ28831103-5D89FC3B-59C9-45C5-B1A2-FBB613264878Q30385237-7EBFD733-B41E-4709-9985-1401CB9F45BBQ31927255-26B3A89D-B9A2-456E-BDAA-36C4C5C408C7Q33316844-AB9C456F-55CB-4944-855A-018556E2F82AQ33545959-A3101BF1-FEA8-46AE-B793-87AE9665543AQ33615916-23848A89-200C-4D60-82C7-EE52AE12E97CQ33617966-F58E5ABB-D572-418E-A509-F7A9901812F1Q33847305-2163ED65-103E-4A46-A9A2-CF4279FCA21CQ33872601-119318D7-BC84-4D03-8337-F8F579515355Q33874156-804EE44E-5070-4462-9E97-332AC57D3854Q33968290-D581E7DC-3197-412E-8F45-146F5820F137Q33976184-7785063D-797C-485E-82CF-C0EB46C9A237Q33979314-B7091678-B5D3-4D97-8470-2F28379F9A45Q33985083-29D05A79-E420-4E91-8C1F-C061AF210FFEQ33990203-5830A5D8-08AA-4EBB-AAAF-0E209EBE9B76Q33991186-B4309761-539A-456B-940F-5EB6C5CD4943Q34000527-7BF8B3C5-029C-4B08-B1CA-3D13431D4C86Q34005616-274512D0-403C-4E3E-A7D5-BE2B27A1CB61Q34065192-132ECC14-EC47-4156-B247-5A3DD45983FDQ34065542-ED7B3223-E336-48D0-80EB-DD88DCCD4703Q34067595-1C2F1AD2-D215-4067-B58A-6B98C2150A40Q34400107-1C7B794A-B19C-4E30-B242-4AE645F54D10Q34565917-FFA027C3-8F7F-4D29-943E-4634EB6BAFCDQ34631019-1CC06199-F395-4A67-9F36-0A034B2CD6EDQ34651968-6E0D81C1-2659-4BBE-A385-908A09AB1564Q34660312-5CA5C3EC-A250-4FB1-868E-7ABDBB5941C8Q34752739-77113EF3-1D03-414B-BB4E-07E7F932281B
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Characterization of a cancer cachectic factor
@ast
Characterization of a cancer cachectic factor
@en
Characterization of a cancer cachectic factor
@nl
type
label
Characterization of a cancer cachectic factor
@ast
Characterization of a cancer cachectic factor
@en
Characterization of a cancer cachectic factor
@nl
prefLabel
Characterization of a cancer cachectic factor
@ast
Characterization of a cancer cachectic factor
@en
Characterization of a cancer cachectic factor
@nl
P2093
P3181
P356
P1433
P1476
Characterization of a cancer cachectic factor
@en
P2093
P2888
P304
P3181
P356
10.1038/379739A0
P407
P577
1996-02-22T00:00:00Z
P6179
1047327490